Categories: DevelopmentDrug
Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.06.2024 | Seed | $32.64M | - |
Mentions in press and media 2
| Date | Title | Description |
| 11.06.2024 | Adcytherix Raises €30M in Seed Funding | Adcytherix, a Marseille, France-based biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC), raised €30M in Seed funding.
The round was led by Pontifax with participation from Pureos Bioventures, RA Ca... |
| - | Adcytherix | “Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.” |
Reviews 0
